A strange silence prevades the exhibition floors of healthcare conventions. Is the current regulatory environment preventing the exchange of scientific information? And what can you, as an exhibitor, do about it?

What effect is the new regulatory environment having on medical meetings, and what does it mean for their future health?

Enticing, engaging, and a magnet for collecting data, interactive exhibits are perfectly suited for pharmaceutical marketing. And while they will never take the place of a sales rep, the purpose is to keep everyone on message and to educate in the process

Designed to rein in the relationship between sales reps and doctors, PhRMA's new, revised code may end up having an adverse effect on clinical trials

Be it a dinner meeting, lunch-and-learn, or teleconference, successful marketing of a brand depends on maximizing peer interaction among professionals

Physcians are balking at attending meetings—a result of one of many regulatory challenges industry meetings planners are besieged with on a weekly basis. A new report reveals what pharmaceutical companies are doing about it.

As oncology grows, its advertising is growing up—leaving behind the mechanistic images and scientific themes of past campaigns

Pharm Exec's 7th annual review of the top companies. We slice and dice the numbers to see who's the best a what. (pdf)

The industry is a-changing. Here are eight seminal events that describe how.